ReP USP - Resultado da busca

Artigo de periodico
Subcutaneous abatacept in patients with polyarticular-course juvenile idiopathic arthritis results from a phase III open-label study (2018)
I, Hermine Brunner; Tzaribachev, Nikolay; Vega-cornejo, Gabriel; Louw, Ingrid; Berman, Alberto; Penades, Inmaculada Calvo; Anton, Jordi; Avila-zapata, Francisco; Cuttica, Ruben; Silva, Clovis Artur Almeida da
Source: Arthritis & rheumatology. Unidade: FM
Subjects: ARTRITE REUMATOIDE JUVENIL, FÁRMACOS ANTIRREUMÁTICOS, INJEÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
I, Hermine Brunner et al. Subcutaneous abatacept in patients with polyarticular-course juvenile idiopathic arthritis results from a phase III open-label study. Arthritis & rheumatology, v. 70, n. 7, p. 1144-1154, 2018Tradução . . Disponível em: https://doi.org/10.1002/art.40466. Acesso em: 28 set. 2024.
APA
I, H. B., Tzaribachev, N., Vega-cornejo, G., Louw, I., Berman, A., Penades, I. C., et al. (2018). Subcutaneous abatacept in patients with polyarticular-course juvenile idiopathic arthritis results from a phase III open-label study. Arthritis & rheumatology, 70( 7), 1144-1154. doi:10.1002/art.40466
NLM
I HB, Tzaribachev N, Vega-cornejo G, Louw I, Berman A, Penades IC, Anton J, Avila-zapata F, Cuttica R, Silva CAA da. Subcutaneous abatacept in patients with polyarticular-course juvenile idiopathic arthritis results from a phase III open-label study [Internet]. Arthritis & rheumatology. 2018 ; 70( 7): 1144-1154.[citado 2024 set. 28 ] Available from: https://doi.org/10.1002/art.40466
Vancouver
I HB, Tzaribachev N, Vega-cornejo G, Louw I, Berman A, Penades IC, Anton J, Avila-zapata F, Cuttica R, Silva CAA da. Subcutaneous abatacept in patients with polyarticular-course juvenile idiopathic arthritis results from a phase III open-label study [Internet]. Arthritis & rheumatology. 2018 ; 70( 7): 1144-1154.[citado 2024 set. 28 ] Available from: https://doi.org/10.1002/art.40466
Artigo de periodico
Prednisone versus prednisone plus ciclosporin versus prednisone plus methotrexate in new-onset juvenile dermatomyositis: a randomised trial (2016)
Ruperto, Nicolino; Pistorio, Angela; Oliveira, Sheila; Zulian, Francesco; Cuttica, Ruben; Ravelli, Angelo; Fischbach, Michel; Magnusson, Bo; Sterba, Gary; Avcin, Tadej; Ferriani, Virgínia Paes Leme
Source: The Lancet. Unidade: FMRP
Subjects: DERMATOPATIAS, MIOSITE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RUPERTO, Nicolino et al. Prednisone versus prednisone plus ciclosporin versus prednisone plus methotrexate in new-onset juvenile dermatomyositis: a randomised trial. The Lancet, v. 387, n. 10019, p. 671-678, 2016Tradução . . Disponível em: https://doi.org/10.1016/s0140-6736(15)01021-1. Acesso em: 28 set. 2024.
APA
Ruperto, N., Pistorio, A., Oliveira, S., Zulian, F., Cuttica, R., Ravelli, A., et al. (2016). Prednisone versus prednisone plus ciclosporin versus prednisone plus methotrexate in new-onset juvenile dermatomyositis: a randomised trial. The Lancet, 387( 10019), 671-678. doi:10.1016/s0140-6736(15)01021-1
NLM
Ruperto N, Pistorio A, Oliveira S, Zulian F, Cuttica R, Ravelli A, Fischbach M, Magnusson B, Sterba G, Avcin T, Ferriani VPL. Prednisone versus prednisone plus ciclosporin versus prednisone plus methotrexate in new-onset juvenile dermatomyositis: a randomised trial [Internet]. The Lancet. 2016 ; 387( 10019): 671-678.[citado 2024 set. 28 ] Available from: https://doi.org/10.1016/s0140-6736(15)01021-1
Vancouver
Ruperto N, Pistorio A, Oliveira S, Zulian F, Cuttica R, Ravelli A, Fischbach M, Magnusson B, Sterba G, Avcin T, Ferriani VPL. Prednisone versus prednisone plus ciclosporin versus prednisone plus methotrexate in new-onset juvenile dermatomyositis: a randomised trial [Internet]. The Lancet. 2016 ; 387( 10019): 671-678.[citado 2024 set. 28 ] Available from: https://doi.org/10.1016/s0140-6736(15)01021-1
Artigo de periodico
Efficacy and safety of tocilizumab in patients with polyarticular-course juvenile idiopathic arthritis: Results from a phase 3, randomised, double-blind withdrawal trial (2015)
Brunner, Hermine I.; Ruperto, Nicolino; Zuber, Zbigniew; Keane, Caroline; Harari, Olivier; Kenwright, Andrew; Lu, Peng; Cuttica, Ruben; Keltsev, Vladimir; Xavier, Ricardo M.; Calvo, Inmaculada; Nikishina, Irina; Rubio-Pérez, Nadina; Alexeeva, Ekaterina; Chasnyk, Vyacheslav; Horneff, Gerd; Opoka-Winiarska, Violetta; Quartier, Pierre; Silva, Clovis A.; Silverman, Earl; Spindler, Alberto; Baildam, Eileen; Gámir, M. Luz; Martin, Alan; Rietschel, Christoph; Siri, Daniel; Smolewska, Elzbieta; Lovell, Daniel; Martini, Alberto; De Benedetti, Fabrizio
Source: Annals of the Rheumatic Diseases. Unidade: FM
Subjects: ANTICORPOS MONOCLONAIS (EFICIÊNCIA;SEGURANÇA), ARTRITE REUMATOIDE, MÉTODO DUPLO-CEGO, ENSAIO CLÍNICO CONTROLADO RANDOMIZADO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BRUNNER, Hermine I. et al. Efficacy and safety of tocilizumab in patients with polyarticular-course juvenile idiopathic arthritis: Results from a phase 3, randomised, double-blind withdrawal trial. Annals of the Rheumatic Diseases, v. 74, n. 6, p. 1110-1117, 2015Tradução . . Disponível em: https://doi.org/10.1136/annrheumdis-2014-205351. Acesso em: 28 set. 2024.
APA
Brunner, H. I., Ruperto, N., Zuber, Z., Keane, C., Harari, O., Kenwright, A., et al. (2015). Efficacy and safety of tocilizumab in patients with polyarticular-course juvenile idiopathic arthritis: Results from a phase 3, randomised, double-blind withdrawal trial. Annals of the Rheumatic Diseases, 74( 6), 1110-1117. doi:10.1136/annrheumdis-2014-205351
NLM
Brunner HI, Ruperto N, Zuber Z, Keane C, Harari O, Kenwright A, Lu P, Cuttica R, Keltsev V, Xavier RM, Calvo I, Nikishina I, Rubio-Pérez N, Alexeeva E, Chasnyk V, Horneff G, Opoka-Winiarska V, Quartier P, Silva CA, Silverman E, Spindler A, Baildam E, Gámir ML, Martin A, Rietschel C, Siri D, Smolewska E, Lovell D, Martini A, De Benedetti F. Efficacy and safety of tocilizumab in patients with polyarticular-course juvenile idiopathic arthritis: Results from a phase 3, randomised, double-blind withdrawal trial [Internet]. Annals of the Rheumatic Diseases. 2015 ; 74( 6): 1110-1117.[citado 2024 set. 28 ] Available from: https://doi.org/10.1136/annrheumdis-2014-205351
Vancouver
Brunner HI, Ruperto N, Zuber Z, Keane C, Harari O, Kenwright A, Lu P, Cuttica R, Keltsev V, Xavier RM, Calvo I, Nikishina I, Rubio-Pérez N, Alexeeva E, Chasnyk V, Horneff G, Opoka-Winiarska V, Quartier P, Silva CA, Silverman E, Spindler A, Baildam E, Gámir ML, Martin A, Rietschel C, Siri D, Smolewska E, Lovell D, Martini A, De Benedetti F. Efficacy and safety of tocilizumab in patients with polyarticular-course juvenile idiopathic arthritis: Results from a phase 3, randomised, double-blind withdrawal trial [Internet]. Annals of the Rheumatic Diseases. 2015 ; 74( 6): 1110-1117.[citado 2024 set. 28 ] Available from: https://doi.org/10.1136/annrheumdis-2014-205351
Artigo de periodico
Health related quality of life measure in systemic pediatric rheumatic diseases and its translation to different languages: an international collaboration (2014)
Moorthy, Lakshmi Nandini; Roy, Elizabeth; Kurra, Vamsi; Peterson, Margaret G. E.; Hassett, Afton L.; Lehman, Thomas J. A.; Scott, Christiaan; El-Ghoneimy, Dalia; Saad, Shereen; El Feky, Reem; Al-Mayouf, Sulaiman; Dolezalova, Pavla; Malcova, Hana; Herlin, Troels; Nielsen, Susan; Wulffraat, Nico; van Royen, Annet; Marks, Stephen D.; Belot, Alexandre; Brunner, Jurgen; Huemer, Christian; Foeldvari, Ivan; Horneff, Gerd; Saurenman, Traudel; Schroeder, Silke; ; Pratsidou-Gertsi, Polyxeni; Trachana, Maria; Uziel, Yosef; Aggarwal, Amita; Constantin, Tamas; Cimaz, Rolando; Giani, Theresa; Cantarini, Luca; Falcini, Fernanda; Manzoni, Silvia Magni; Ravelli, Angelo; Rigante, Donato; Zulian, Fracnceso; Miyamae, Takako; Yokota, Shumpei; Sato, Juliana; Magalhaes, Claudia S.; Len, Claudio A.; Appenzeller, Simone; Knupp, Sheila Oliveira; Rodrigues, Marta Cristine; Sztajnbok, Flavio; Almeida, Rozana Gasparello de; Jesus, Adriana Almeida de; Campos, Lucia Maria de Arruda; Silva, Clovis; Lazar, Calin; Susic, Gordana; Avcin, Tadej; Cuttica, Ruben; Burgos-Vargas, Ruben; Faugier, Enrique; Anton, Jordi; Modesto, Consuelo; Vazquez, Liza; Barillas, Lilliana; Barinstein, Laura; Sterba, Gary; Maldonado, Irama; Ozen, Seza; Kasapcopur, Ozgur; Demirkaya, Erkan; Benseler, Susa
Source: Pediatric Rheumatology. Unidade: FM
Subjects: LÚPUS ERITEMATOSO SISTÊMICO, QUALIDADE DE VIDA, FÁRMACOS ANTIRREUMÁTICOS, DOENÇAS REUMÁTICAS (TERAPIA)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MOORTHY, Lakshmi Nandini et al. Health related quality of life measure in systemic pediatric rheumatic diseases and its translation to different languages: an international collaboration. Pediatric Rheumatology, v. 12, n. 1, p. 6 , 2014Tradução . . Disponível em: https://doi.org/10.1186/1546-0096-12-49. Acesso em: 28 set. 2024.
APA
Moorthy, L. N., Roy, E., Kurra, V., Peterson, M. G. E., Hassett, A. L., Lehman, T. J. A., et al. (2014). Health related quality of life measure in systemic pediatric rheumatic diseases and its translation to different languages: an international collaboration. Pediatric Rheumatology, 12( 1), 6 . doi:10.1186/1546-0096-12-49
NLM
Moorthy LN, Roy E, Kurra V, Peterson MGE, Hassett AL, Lehman TJA, Scott C, El-Ghoneimy D, Saad S, El Feky R, Al-Mayouf S, Dolezalova P, Malcova H, Herlin T, Nielsen S, Wulffraat N, van Royen A, Marks SD, Belot A, Brunner J, Huemer C, Foeldvari I, Horneff G, Saurenman T, Schroeder S, , Pratsidou-Gertsi P, Trachana M, Uziel Y, Aggarwal A, Constantin T, Cimaz R, Giani T, Cantarini L, Falcini F, Manzoni SM, Ravelli A, Rigante D, Zulian F, Miyamae T, Yokota S, Sato J, Magalhaes CS, Len CA, Appenzeller S, Knupp SO, Rodrigues MC, Sztajnbok F, Almeida RG de, Jesus AA de, Campos LM de A, Silva C, Lazar C, Susic G, Avcin T, Cuttica R, Burgos-Vargas R, Faugier E, Anton J, Modesto C, Vazquez L, Barillas L, Barinstein L, Sterba G, Maldonado I, Ozen S, Kasapcopur O, Demirkaya E, Benseler S. Health related quality of life measure in systemic pediatric rheumatic diseases and its translation to different languages: an international collaboration [Internet]. Pediatric Rheumatology. 2014 ; 12( 1): 6 .[citado 2024 set. 28 ] Available from: https://doi.org/10.1186/1546-0096-12-49
Vancouver
Moorthy LN, Roy E, Kurra V, Peterson MGE, Hassett AL, Lehman TJA, Scott C, El-Ghoneimy D, Saad S, El Feky R, Al-Mayouf S, Dolezalova P, Malcova H, Herlin T, Nielsen S, Wulffraat N, van Royen A, Marks SD, Belot A, Brunner J, Huemer C, Foeldvari I, Horneff G, Saurenman T, Schroeder S, , Pratsidou-Gertsi P, Trachana M, Uziel Y, Aggarwal A, Constantin T, Cimaz R, Giani T, Cantarini L, Falcini F, Manzoni SM, Ravelli A, Rigante D, Zulian F, Miyamae T, Yokota S, Sato J, Magalhaes CS, Len CA, Appenzeller S, Knupp SO, Rodrigues MC, Sztajnbok F, Almeida RG de, Jesus AA de, Campos LM de A, Silva C, Lazar C, Susic G, Avcin T, Cuttica R, Burgos-Vargas R, Faugier E, Anton J, Modesto C, Vazquez L, Barillas L, Barinstein L, Sterba G, Maldonado I, Ozen S, Kasapcopur O, Demirkaya E, Benseler S. Health related quality of life measure in systemic pediatric rheumatic diseases and its translation to different languages: an international collaboration [Internet]. Pediatric Rheumatology. 2014 ; 12( 1): 6 .[citado 2024 set. 28 ] Available from: https://doi.org/10.1186/1546-0096-12-49

USP Schools

ReP

Filtros

Authors

Subjects

Indexado em

Non normalized affiliation

Countries of institutions of collaboration